Clinical Trials Logo
  1. Home
  2. Phenylketonuria (PKU)
  3. NCT04086511

PANDA: PKU Amino Acid Evaluation — PANDA  

Phenylketonuria (PKU) Clinical Trial

Official title:
PANDA: A Cross-sectional Study to Measure Blood Amino Acid Levels in PKU Children on a Protein Substitute

Clinical Trial Summary

Phenylketonuria (PKU) is a rare inherited metabolic disorder, where subjects are born with a genetic deficiency in the phenylalanine hydroxylase enzyme (PAH), which leaves them unable to convert Phenylalanine (Phe) into Tyrosine (Tyr). PKU patients have specific dietary needs and must follow a restrictive diet in the aim of preventing toxic levels of the amino acid phenylalanine (Phe) accumulation.

Clinical Trial Description

The exploratory study's main objective is to measure blood amino acid levels and to gain quantitative insights in children with PKU on a protein substitute with respect to evaluation of nutritional intake. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04086511
Study type Observational
Source Nutricia Research
Contact
Status Completed
Phase
Start date September 10, 2019
Completion date April 14, 2023
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04480567 - AAV Gene Therapy Study for Subjects With PKU Phase 1/Phase 2
Completed NCT03694353 - Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU Phase 3
Completed NCT02440932 - Impact of Phenylketonuria-type Diet on Appetite, Appetite Hormones and Diet Induced Thermogenesis N/A
Completed NCT01617070 - Effects of Kuvan on Melatonin Secretion Phase 4
Completed NCT03505125 - A Non-Interventional Interview Study of Phenylketonuria (PKU) Adults
Terminated NCT01806051 - A Pilot Study on Diurnal Variation N/A
Recruiting NCT05813678 - A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)
Active, not recruiting NCT05270837 - Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria Phase 3
Completed NCT01889862 - Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU Phase 3
Completed NCT02009904 - Simple Breath Test to Examine Phenylalanine Metabolism
Recruiting NCT06305234 - A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)
Recruiting NCT03309345 - Body Composition, Energy Intake and Expenditure in People With Phenylketonuria N/A